GeneDx Holdings Corp. (NASDAQ:WGS) — Market Cap & Net Worth
Market Cap & Net Worth: GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. (NASDAQ:WGS) has a market capitalization of $2.01 Billion ($2.01 Billion) as of October 10, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6096 globally and #1946 in its home market, demonstrating a -5.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GeneDx Holdings Corp.'s stock price $67.33 by its total outstanding shares 29822541 (29.82 Million).
GeneDx Holdings Corp. Market Cap History: 2020 to 2026
GeneDx Holdings Corp.'s market capitalization history from 2020 to 2026. Data shows change from $10.86 Billion to $2.01 Billion (-23.25% CAGR). Check GeneDx Holdings Corp. share price for real-time trading data and today's change.
Index Memberships
GeneDx Holdings Corp. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.08% | #164 of 976 |
|
NASDAQ Composite
IXIC
|
$42.19 Trillion | 0.00% | #685 of 3165 |
Weight: GeneDx Holdings Corp.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GeneDx Holdings Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GeneDx Holdings Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see WGS cash flow metrics for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
9.07x
GeneDx Holdings Corp.'s market cap is 9.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $10.86 Billion | $179.32 Million | -$241.34 Million | 60.59x | N/A |
| 2021 | $4.39 Billion | $212.19 Million | -$245.39 Million | 20.69x | N/A |
| 2022 | $259.81 Million | $234.69 Million | -$548.98 Million | 1.11x | N/A |
| 2023 | $82.01 Million | $202.57 Million | -$175.77 Million | 0.40x | N/A |
| 2024 | $2.30 Billion | $305.45 Million | -$52.29 Million | 7.53x | N/A |
| 2025 | $3.88 Billion | $427.54 Million | -$21.02 Million | 9.07x | N/A |
Competitor Companies of WGS by Market Capitalization
Companies near GeneDx Holdings Corp. in the global market cap rankings as of October 10, 2026. See debt-free asset ratio of GeneDx Holdings Corp. to understand what proportion of total assets are financed by equity.
Key companies related to GeneDx Holdings Corp. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #155 globally with a market cap of $155.26 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #477 globally with a market cap of $57.11 Billion USD ( CN¥390.28 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #580 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $658.02 |
| #155 | Danaher Corporation | NYSE:DHR | $155.26 Billion | $219.81 |
| #477 | WuXi AppTec Co Ltd | SHG:603259 | $57.11 Billion | CN¥157.80 |
| #580 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $400.71 |
GeneDx Holdings Corp. Historical Marketcap From 2020 to 2026
Between 2020 and today, GeneDx Holdings Corp.'s market cap moved from $10.86 Billion to $ 2.01 Billion, with a yearly change of -23.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.01 Billion | -48.23% |
| 2025 | $3.88 Billion | +68.73% |
| 2024 | $2.30 Billion | +2702.91% |
| 2023 | $82.01 Million | -68.43% |
| 2022 | $259.81 Million | -94.08% |
| 2021 | $4.39 Billion | -59.60% |
| 2020 | $10.86 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 10th, 2026 the market cap of GeneDx Holdings Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.01 Billion USD |
| MoneyControl | $2.01 Billion USD |
| MarketWatch | $2.01 Billion USD |
| marketcap.company | $2.01 Billion USD |
| Reuters | $2.01 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and can… Read more